Clinical studies recruiting near Hilversum

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Tergooiziekenhuizen, locatie Hilversum · Pfizer · NCT07028853 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Tergooiziekenhuizen, locatie Hilversum · Amgen · NCT07037433 Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy.
NA · Merem · Amsterdam UMC, location VUmc · NCT06640894 Hold me Tight/Let me Go: Effectiveness of a Course to Enhance Parent-adolescent Relationship
Phase N/A · Molemann Mental Health · University of Amsterdam · NCT06966323 Hip-allograft In Proximal Humerus Fractures Versus Plate Implantation Alone: a Randomized Controlled Trial
NA · Tergooi Medical Center · Tergooi Medical Center · NCT07538700 Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Phase N/A · Tergooi Hospital · Maastricht University Medical Center · NCT04486495 The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Diseas
NA · Tergooi MC · Alzheimercentrum Amsterdam · NCT07680335 Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · Tergooi MC · Catharina Ziekenhuis Eindhoven · NCT05405270 Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Phase 2 · Tergooi · The Netherlands Cancer Institute · NCT03026140 National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Phase N/A · Tergooi MC · PROspective Renal Cancer Cohort Foundation · NCT05326620 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Tergooiziekenhuizen, locatie Hilversum · Eli Lilly and Company · NCT06119581 Prospective Data Collection Initiative on Thoracic Malignancies
Phase N/A · Tergooi MC · Dutch Society of Physicians for Pulmonology and Tuberculosis · NCT06996249 A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVAT
Phase 3 · Zai Lab Site 20004 · Zai Lab (Shanghai) Co., Ltd. · NCT07218146 A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compar
Phase 3 · Tergooi Mc · BeOne Medicines · NCT06943872 A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)
Phase N/A · Tergooi MC · Translumina Therapeutics Pvt Ltd. · NCT06412250 Prospective Data Collection Initiative on Colorectal Cancer
Phase N/A · Tergooi · Dutch Colorectal Cancer Group · NCT02070146 Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Phase 3 · Tergooiziekenhuizen, locatie Hilversum · Amgen · NCT07293260 The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NA · Tergooi MC · Radboud University Medical Center · NCT06082492 FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethas
Phase 3 · NL-Hilversum-TERGOOI · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT06187441 Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma
Phase 3 · NL-Hilversum-TERGOOI · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT06220032 OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infi
Phase N/A · Tergooi ziekenhuizen · The Netherlands Cancer Institute · NCT06476119 Brain STimulation for Arm Recovery After Stroke 2
NA · Merem · Jord Vink · NCT06265766 The Drug Rediscovery Protocol (DRUP Trial)
Phase 2 · Tergooi MC · The Netherlands Cancer Institute · NCT02925234 What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
Phase 4 · Tergooi MC · St. Antonius Hospital · NCT04436978 Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic
Phase 3 · Tergooi MC · Nick Beije · NCT07260435 A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Phase 3 · Tergooiziekenhuizen, locatie Hilversum ( Site 0619) · Merck Sharp & Dohme LLC · NCT06925737 DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer
Phase 3 · Tergooi MC · Leiden University Medical Center · NCT06275958 Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · Tergooiziekenhuizen, locatie Hilversum · Eli Lilly and Company · NCT07157774 Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
Phase 3 · Tergooiziekenhuizen · UNICANCER · NCT07237256 Improved Prescribing for Older Nursing Home Patients
NA · Amaris, Location Alporti and Rubina · Amsterdam UMC, location VUmc · NCT06731361

Look up another city

Look up another condition